Answer
Eptacog beta (activated) competes with activated protein C for binding to the endothelial protein C receptor, thereby limiting activated protein C-mediated cleavage of factor Va, the factor Xa cofactor, and reducing anticoagulation.
Sources for this answer
- CEVENFACTA 1 mg (45 KIU) powder and solvent for solution for injectionLFB Biopharmaceuticals Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 2Document updated
Sources checked